Drugs / CBD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT06656806 Comparator | Dec 2024 → May 2025 overdue | generalized anxiety disorder | Trinity Hypertension & Metabolic Research Institute | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06656806 ↗ |
| Route | Inhaled | “treated with inhaled CBD” NCT06656806 ↗ |